Abbott Projects Full-Year 2024 Adjusted EPS Of $4.64 To $4.70 Versus Prior Guidance Of $4.61-$4.71 And Consensus Of $4.66
Portfolio Pulse from Benzinga Newsdesk
Abbott has updated its full-year 2024 adjusted EPS guidance to a range of $4.64 to $4.70, slightly narrowing its previous range of $4.61 to $4.71. This new guidance aligns closely with the consensus estimate of $4.66.

October 16, 2024 | 11:34 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Abbott has revised its full-year 2024 adjusted EPS guidance to $4.64-$4.70, slightly narrowing the range and aligning with the consensus estimate of $4.66. This indicates stable financial expectations.
Abbott's updated EPS guidance is a slight adjustment from its previous range and aligns with market expectations. This suggests stability in its financial outlook, likely resulting in a neutral short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100